Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 243, Issue 6, 2005, Pages 531-538

  Brignole, Françoise ^a   Pisella, Pierre Jean ^b   Dupas, Bénédicte ^c   Baeyens, Vincent ^d   Baudouin, Christophe ^c,e  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITY HOSPITAL OF TOURS   (France)

^c CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^d TRB Chemedica International SA   (Switzerland)

^e LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

CD44; Dry eye; Sodium hyaluronate

Indexed keywords

CARBOXYMETHYLCELLULOSE; HERMES ANTIGEN; HLA DR ANTIGEN; HYALURONIC ACID; VISMED;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRY EYE; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; IMPRESSION CYTOLOGY; KERATITIS; MALE; PARALLEL DESIGN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VISUAL ANALOG SCALE; VISUAL IMPAIRMENT;

AGED; CARBOXYMETHYLCELLULOSE; CONJUNCTIVA; CORNEA; CORNEAL TOPOGRAPHY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRY EYE SYNDROMES; FEMALE; FLOW CYTOMETRY; FLUORESCEIN; FLUORESCENT DYES; FOLLOW-UP STUDIES; HUMANS; HYALURONIC ACID; KERATITIS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TREATMENT OUTCOME; VISCOSUPPLEMENTS;

EID: 22144480688     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-004-1040-6     Document Type: Article

References (35)

1. Aziz KE, Wakefield D (1995) In vivo and in vitro expression of adhesion molecules by peripheral blood lymphocytes from patients with primary Sjogren's syndrome: Culture-associated enhancement of LECAM-1 and CD44. Rheumatol Int 15:69-74. 10.1007/BF00262711
2. Baudouin C (2001) The pathology of dry eye. Surv Ophthalmol 45:S211-S220. 10.1016/S0039-6257(00)00200-9
3. Baudouin C, Haouat N, Brignole F, Bayle J, Gastaud P (1992) Immunopathological findings in conjunctival cells using immunofluorescence staining of impression cytology specimens. Br J Ophthalmol 76:545-549
4. Baudouin C, Brignole F, Becquet F, Pisella PJ, Goguel A (1997) Flow cytometry in impression cytology specimens. Invest Ophthalmol Vis Sci 38:1458-1464. 1:STN:280:ByiA3svpsVA%3D
5. SF Bernatchez O Camber C Tabatabay R Gurny 1993 Use of hyaluronic acid in ocular therapy In P Edman (ed) Biopharmaceutics of ocular drug delivery CRC Boca Raton 105-120
6. Bernatchez SF, Tabatabay C, Gurny R (1993) Sodium hyaluronate 0.25% used as a vehicle increases the bioavailability of topically administered gentamicin. Graefes Arch Clin Exp Ophthalmol 231:157-171
7. Brignole F, De Saint-Jean M, Goldschild M, Becquet F, Goguel A, Baudouin C (1998) Expression of Fas-Fas ligand antigens and apoptotic marker AP02.7 by the human conjunctival epithelium, positive correlation with Class II HLA DR expression in inflammatory ocular surface disorders. Exp Eye Res 67:687-697. 10.1006/exer.1998.0566
8. Cerulli L, Trematerra M, Zapelloni A, D'Ambrosi E, Corsi A (1993) Clinical evaluation of L02A eye drop versus control eye drop in patients suffering from lacrymal hyposecretion. Ann Ottalmol Clin Ocul 119:49-55
9. Condon PI, McEwen CG, Wright M, Mackintosh G, Prescott RJ, McDonald C (1999) Double-blind, randomised, placebo-controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndrome. Br J Ophthalmol 83:1121-1124
10. Fukuda M (1991) Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. J Biol Chem 266:21327-21330. 1:CAS:528:DyaK3MXmt1KhsLo%3D
11. Gomes JAP, Amankwah R, Powell-Richards A, Dua HS (2004) Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro. Br J Ophthalmol 88:821-825
12. Gurny R, Ryser JE, Tabatabay C, Martenet M, Edman P, Camber O (1990) Precorneal residence time in humans of sodium hyaluronate as measured by gamma scintigraphy. Graefes Arch Clin Exp Ophthalmol 228:510-512
13. Hamano T, Horimoto K, Lee M, Komemushi S (1996) Sodium hyaluronate eye drops enhance tear film stability. Jpn J Ophthalmol 40:62-65. 1:CAS:528:DyaK28XivFahs70%3D
14. Iester A, Brezzo MV, Rolando M (1993) Double-masked clinical trial of an unpreserved hyaluronic acid based eye drop in dry eye syndromes. Ann Ottalmol Clin Ocul 119:17-31
15. Lemp MA (1995) Report of the National Eye Institute/Industry Workshop on clinical trials in dry eyes. CLAO J 21:221-232. 1:STN:280:BymC38%2FnsFE%3D
16. Levesque MC, Mackin DA, Fleming JA, St Clair EW (2000) Serum levels of soluble CD44 in primary Sjogren's syndrome. J Rheumatol 27:1444-1449. 1:CAS:528:DC%2BD3cXktlKiu7k%3D
17. Limberg MB, Mc Caa C, Kissling GE, Kaufman HE (1987) Topical application of hyaluronic acid and chondroitin sulfate in the treatment of dry eyes. Am J Ophthalmol 103:194-197
18. McMonnies CW (1986) Key questions in a dry eye history. J Am Optom Assoc 57:512-517. 1:STN:280:BimA3crltVQ%3D
19. McMonnies CW, Ho A (1987) Patient history in screening for dry eye conditions. J Am Optom Assoc 58:296-301. 1:STN:280:BiiB38zmslY%3D
20. McMonnies CW, Ho A (1987) Responses to a dry eye questionnaire from a normal population. J Am Optom Assoc 58:588-591. 1:STN:280:BieD3svhvVI%3D
21. Mengher L, Pandher K, Bron AJ, Davey CC (1986) Effect of sodium hyaluronate (0.1%) on break-up time (NIBUT) in patients with dry eyes. Br J Ophthalmol 70:442-447
22. Meyer K (1958) Chemical structure of hyaluronic acid. Fed Proc 17:1075-1077. 1:CAS:528:DyaG1MXksFCntg%3D%3D
23. Miyazaki T, Miyauchi S, Nakamura T, Takeshita S, Horie K (1996) The effect of sodium hyaluronate on the growth of rabbit corneal epithelial cells in vitro. J Ocul Pharmacol Ther 12:409-415. 1:CAS:528:DyaK28Xns1ShtL4%3D
24. Nagy H, Goda K, Fenyvesi F, Bacso Z, Szilasi M, Kappelmayer J, Lustyik G, Cianfriglia M, Szabo G Jr (2004) Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies. Biochem Biophys Res Commun 315:942-949. 10.1016/j.bbrc.2004.01.156
25. Nakamura M, Hikida M, Nakano T (1992) Concentration and molecular weight dependency of rabbit corneal epithelial wound healing on hyaluronan. Curr Eye Res 11:981-986. 1:STN:280:ByyD1czisVA%3D
26. Nakamura M, Nakano T, Mibu H, Hikida M (1995) Hyaluronan stimulates epithelial wound healing in the rabbit cornea. Folia Ophthalmol Jpn 46:1256-1260
27. Orsoni JG, Chiari M, Guazi A, De Carli M, Guidolin D (1988) Efficacy of hyaluronic acid solution in the treatment of sicca syndrome. Ophtalmologie 2:355-357. 1:STN:280:BiaB3sblvF0%3D
28. Pisella PJ, Debbasch C, Hamard P, Creuzot-Garcher C, Rat P, Brignole F, Baudouin C (2004) Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: An ex vivo and in vitro study. Invest Ophthalmol Vis Sci 45:1360-1368
29. Sand BB, Marner K, Norn MS (1989) Sodium hyaluronate in the treatment of keratoconjunctivitis sicca. A double masked clinical trial. Acta Ophthalmol 67:181-183
30. Scrivanti M, Taiti L, Mencucci R., Bardi L, Salvi G (1996) Syndrome sec oculaire: Utilisation d'un nouveau substitut lacrymal (LO2A). Ophtalmologie 10:24-27
31. Shimmura S, Ono M, Shinozaki K, Toda I, Takamura E, Mashima Y, Tsubota K (1995) Sodium hyaluronate eye drops in the treatment of dry eyes. Br J Ophthalmol 79:1007-1011
32. Skubitz KM, Campbell KD, Skubitz AP (2000) CD63 associates with CD11/ CD18 in large detergent-resistant complexes after translocation to the cell surface in human neutrophils. FEBS Lett 469:52-56. 10.1016/ S0014-5793(00)01240-0
33. Taiti L, Scrivanti M, Mencucci R, Bardi L, Salvi G (1996) A double-masked crossover comparison of a new artificial tear preparation containing hyaluronic acid (L02A) and a reference artificial tear preparation containing hydroxypropyl-methylcellulose in dry-eye syndrome treatment. Ann Ottalmol Clin Ocul 119:33-46
34. Tiffany JM (1994) Viscoelastic properties of human tears and polymer solutions. Adv Exp Med Biol 350:267-270. 1:STN:280:ByuA3czltVY%3D
35. Zhu SN, Nolle B, Duncker G (1997) Expression of adhesion molecule CD44 on human corneas. Br J Ophthalmol 81:80-84. 1:STN:280:ByuA3czltVY%3D